A Natural Anticancer Agent Thaspine Targets Human Topoisomerase IB

Author(s): Silvia Castelli, Prafulla Katkar, Oscar Vassallo, Mattia Falconi, Stig Linder, Alessandro Desideri

Journal Name: Anti-Cancer Agents in Medicinal Chemistry
(Formerly Current Medicinal Chemistry - Anti-Cancer Agents)

Volume 13 , Issue 2 , 2013

Become EABM
Become Reviewer
Call for Editor


The different steps of the topoisomerase I catalytic cycle have been analyzed in the presence of the plant alkaloid thaspine (1- (2-(Dimethylamino)ethyl)-3,8-dimethoxychromeno[5,4,3-cde]chromene-5,10-dione), known to induce apoptosis in colon carcinoma cells. The experiments indicate that thaspine inhibits both the cleavage and the religation steps of the enzyme reaction. The inhibition is reversible and the effect is enhanced upon pre-incubation. Molecular docking simulations of thaspine over topoisomerase I, in the presence or absence of the DNA substrate, show that thaspine, when interacting with the enzyme alone in the closed or in the open state, can bind in proximity of the active residues preventing the cleavage reaction, whilst when docked with the enzyme-DNA cleavable complex intercalates between the DNA bases in a way similar to that found for camptothecin, explaining its religation inhibition. These results unequivocally demonstrate that thaspine targets human topoisomerase I .

Keywords: Camptothecin, Human topoisomerase IB, Inhibitor, Molecular docking, Thaspine

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2013
Published on: 15 January, 2013
Page: [356 - 363]
Pages: 8
DOI: 10.2174/1871520611313020021
Price: $65

Article Metrics

PDF: 16